Clinic Software← All companies
SynchNeuro, Inc.
The world’s first non-invasive, brain-based continuous glucose monitor.
health AImedtechwearablesdigital health
StageSeed
Raised$3 million
Founded2021
Employees9
LocationChicago, IL
About
At SynchNeuro, we are transforming how people monitor and manage their health with the world’s first non-invasive brain-based continuous glucose monitor. Our sensor, discreetly worn behind the ear, analyzes brain signals to track blood glucose levels, sleep quality, and other vital health metrics. This breakthrough technology offers a pain-free, convenient, effective and inexpensive alternative to traditional glucose monitoring methods.
Product
- Value proposition
- Non-invasive brain-based wearable sensor that continuously monitors glucose and metabolic health in real time, providing pain-free, convenient monitoring as an alternative to traditional methods.
- Target customers
- Individuals with prediabetes/diabetes, healthcare providers, researchers, and medtech investors/accelerators
Founders
- Casey Halpern — Co-Founder & Chairman
- Emily Mirro — President & Co-Founder
Categories
Products
Brainwave sensor (behind-the-ear)EEG-based glucose/metabolic monitoringMachine-learning health analytics
Key features
Non-invasive brain-based continuous glucose monitoringBehind-the-ear wearable sensorReal-time metabolic health metrics including glucose and sleep qualityEEG-based prediction of glucose levelsPain-free, convenient alternative to traditional monitoring
Technologies
EEG/Brain signalsMachine learningWearable sensorsNon-invasive monitoring
Target conditions
PrediabetesDiabetesMetabolic HealthSleep Quality (related metrics)
Care settings
HomeClinicWearable/Personal Monitoring
Certifications
HIPAA (assumed for healthcare data handling, not explicitly stated)
Notable customers
Boomerang Ventures (investor)MedTech Innovator (industry context)Plug and Play Lifetech (accelerator/partner)
Partnerships
Boomerang Ventures (seed funding)Plug and Play Lifetech Indianapolis batch partner
Traction metrics
Seed funding completed (Boomerang Ventures)Participation in incubator/accelerator programsMedia coverage linked in extracted extras
Investors
Boomerang Ventures
News
- SynchNeuro's CGM Could Measure Glucose Levels Using Brainwaves · 2025-10-27T00:00:00.000Z
- SynchNeuro Has a Working Prototype, a New Study Launching, and a Forecast for Your Blood Sugar | Health Moonshot Update · 2026-05-27T22:02:25.000Z
- SynchNeuro: A Neurosurgeon's Surprising Leap into Cardiometabolic Care — StartUp Health · 2025-06-17T17:30:00.000Z
- SynchNeuro Invents First Non-Invasive, EEG-Based Continuous Glucose Monitor — StartUp Health · 2024-12-13T22:05:22.000Z
- Neurotech Enters Everyday Wellness | Fitt Insider · 2025-11-25T21:06:52.000Z
- Health Transformer Spotlight: Meet Emily Mirro from SynchNeuro, Focused on Innovative Solutions for Individuals with Prediabetes — StartUp Health · 2025-08-07T17:51:22.000Z
